ScholarIQanswers from OpenAlex

PO-02-006 AN ECONOMIC EVALUATION OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A UNITED STATES MEDICARE PERSPECTIVE

PaperCitations, authors & open-access status

PO-02-006 AN ECONOMIC EVALUATION OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A UNITED STATES MEDICARE PERSPECTIVE is a paper indexed in ScholarIQ from OpenAlex.

How many citations does PO-02-006 AN ECONOMIC EVALUATION OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A UNITED STATES MEDICARE PERSPECTIVE have?

ScholarIQcitation count

PO-02-006 AN ECONOMIC EVALUATION OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A UNITED STATES MEDICARE PERSPECTIVE has 0 citations in the OpenAlex counts ScholarIQ stores.

When was PO-02-006 AN ECONOMIC EVALUATION OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A UNITED STATES MEDICARE PERSPECTIVE published?

ScholarIQyear

PO-02-006 AN ECONOMIC EVALUATION OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A UNITED STATES MEDICARE PERSPECTIVE has 2023 year in the ScholarIQ index.

What is the open-access status of PO-02-006 AN ECONOMIC EVALUATION OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A UNITED STATES MEDICARE PERSPECTIVE?

ScholarIQoa status

PO-02-006 AN ECONOMIC EVALUATION OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A UNITED STATES MEDICARE PERSPECTIVE has bronze oa status in the ScholarIQ index.

What is the DOI of PO-02-006 AN ECONOMIC EVALUATION OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A UNITED STATES MEDICARE PERSPECTIVE?

ScholarIQdoi

The DOI for PO-02-006 AN ECONOMIC EVALUATION OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A UNITED STATES MEDICARE PERSPECTIVE is on the source record.

What is the OpenAlex record for PO-02-006 AN ECONOMIC EVALUATION OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A UNITED STATES MEDICARE PERSPECTIVE?

ScholarIQopenalex

The OpenAlex for PO-02-006 AN ECONOMIC EVALUATION OF FIRST-LINE CRYOBALLOON ABLATION VERSUS ANTIARRHYTHMIC DRUG THERAPY FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION FROM A UNITED STATES MEDICARE PERSPECTIVE is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial